SCHEMBL6774236

SCHEMBL6774236

COc1ccc(OCc2ccccc2N)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.50
PRSS1 P07477 1/20 0.50
PRSS2 P07478 1/20 0.50
PRSS3 P35030 1/20 0.50
TMPRSS6 Q8IU80 1/20 0.50
ST14 Q9Y5Y6 1/20 0.50
MAOB P27338 4/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
MAPT P10636 3/20 0.46
HPGD P15428 1/20 0.46
ATM Q13315 1/20 0.46
RAB9A P51151 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
NPC1 O15118 2/20 0.45
ALDH1A1 P00352 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
GAA P10253 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
THRB P10828 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12182466 0.85 F2 (0.50) F2PRSS1PRSS2PRSS3TMPRSS6
SCHEMBL23456171 0.84 F2 (0.52) F2PRSS1PRSS2PRSS3TMPRSS6
SCHEMBL17554460 0.83 F2 (0.56) F2PRSS1PRSS2PRSS3TMPRSS6
SCHEMBL17574388 0.82 MAOB (0.49) F2PRSS1PRSS2PRSS3TMPRSS6
SCHEMBL26581181 0.81 F2 (0.46) F2PRSS1PRSS2PRSS3TMPRSS6
SCHEMBL13761546 0.81 APP (0.49) F2PRSS1PRSS2PRSS3TMPRSS6
SCHEMBL11604767 0.81 MAOB (0.51) MAOBL3MBTL1MAPTRAB9ASMN1; SMN2
SCHEMBL1154799 0.79 CD274 (0.43) MAOBMAPTATMRAB9ASMN1; SMN2
SCHEMBL21340831 0.78 MAOB (0.65) MAOBMAPTRAB9ASMN1; SMN2NPC1
SCHEMBL27959725 0.78 SMN1; SMN2 (0.47) F2PRSS1PRSS2PRSS3TMPRSS6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6677369-B2 CARBOXIMIDAMIDE DERIVATIVE ANTICOAGULANTS INHIBIT FACTOR XA ELI LILLY AND COMPANY 2004-01-13 US disclosed
US-20030195223-A1 An anticoagulant, blood inhibitor of factor Xa, a N1-amidinebenzoyl- N2-benzoyl-1,2-benzenediamine derivatives; chemical intermediates BEIGHT DOUGLAS WADE (US) 2003-10-16 US disclosed
US-6417200-B1 BLOOD COAGULATION FACTOR XA IN MAMMALS ELI LILLY AND COMPANY 2002-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030195223-A1 An anticoagulant, blood inhibitor of factor Xa, a N1-amidinebenzoyl- N2-benzoyl-1,2-benzenediamine derivatives; chemical intermediates F12, F11, F2 F2 3/4885PRSS1 134/4885PRSS2 301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.